| HCVAX | OCGCX | HCVAX / OCGCX | |
| Total Expense Ratio | 1.01 | 1.42 | 71% |
| Annual Report Gross Expense Ratio | 1.01 | 1.42 | 71% |
| Fund Existence | 22 years | 29 years | - |
| Gain YTD | 4.946 | 3.365 | 147% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 500 | 400% |
| Min. Initial Investment IRA | 2000 | N/A | - |
| Net Assets | 141M | 4.47B | 3% |
| Annual Yield % from dividends | 3.07 | 2.75 | 112% |
| Returns for 1 year | 9.10 | 5.70 | 160% |
| Returns for 3 years | 34.24 | 24.28 | 141% |
| Returns for 5 years | 16.38 | 7.15 | 229% |
| Returns for 10 years | 56.97 | 27.14 | 210% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SMFCX | 23.80 | 0.25 | +1.06% |
| American Beacon Stephens Mid-Cap Gr C | |||
| LDFVX | 17.83 | 0.11 | +0.62% |
| Lord Abbett Fundamental Equity A | |||
| JAVAX | 18.36 | 0.11 | +0.60% |
| James Aggressive Allocation | |||
| MIRGX | 39.32 | 0.19 | +0.49% |
| MFS Massachusetts Inv Gr Stk R2 | |||
| CEIIX | 15.19 | N/A | N/A |
| Manning & Napier Callodine Equity Inc I | |||